These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2975610

  • 1. Effect of long-term treatment with celiprolol on pulmonary function in a group of mild hypertensive asthmatics.
    Clauzel AM, Jean T, Etienne R, Visier S, Michel F.
    J Int Med Res; 1988; 16 Suppl 1():27A-33A. PubMed ID: 2975610
    [Abstract] [Full Text] [Related]

  • 2. Bronchoneutral effects in hypertensive asthmatics--celiprolol versus chlorthalidone.
    Dorow P.
    J Int Med Res; 1988; 16 Suppl 1():23A-26A. PubMed ID: 2975609
    [Abstract] [Full Text] [Related]

  • 3. Bronchosparing properties of celiprolol, a new beta 1, alpha 2-blocker, in propranolol-sensitive asthmatic patients.
    Matthys H, Doshan HD, Rühle KH, Applin WJ, Braig H, Pohl M.
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S40-2. PubMed ID: 2427851
    [Abstract] [Full Text] [Related]

  • 4. Celiprolol--review of airways studies.
    Dorow P.
    Am J Cardiol; 1988 Feb 10; 61(5):23C-26C. PubMed ID: 2963522
    [Abstract] [Full Text] [Related]

  • 5. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients.
    Doshan HD, Rosenthal RR, Brown R, Slutsky A, Applin WJ, Caruso FS.
    J Cardiovasc Pharmacol; 1986 Feb 10; 8 Suppl 4():S105-8. PubMed ID: 2427836
    [Abstract] [Full Text] [Related]

  • 6. A comparison of celiprolol and chlorthalidone in hypertensive patients with reversible bronchial obstruction.
    Dorow P, Clauzel AM, Capone P, Mayol R, Mathieu M.
    J Cardiovasc Pharmacol; 1986 Feb 10; 8 Suppl 4():S102-4. PubMed ID: 2427835
    [Abstract] [Full Text] [Related]

  • 7. Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension.
    van Zyl AI, Jennings AA, Bateman ED, Opie LH.
    Chest; 1989 Jan 10; 95(1):209-13. PubMed ID: 2562825
    [Abstract] [Full Text] [Related]

  • 8. [Safety and efficacy of celiprolol in hypertensive patients with chronic obstructive lung disease].
    Chahuán M, Corradi L, Román O, Bravo C.
    Rev Med Chil; 2000 Jan 10; 128(1):59-63. PubMed ID: 10883523
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of hypertensive hyperuricemic patients with a new beta blocker-diuretic combination].
    Brandstetter G, Hoffmann H.
    Wien Klin Wochenschr; 1984 Sep 28; 96(18):696-9. PubMed ID: 6240831
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis.
    Tirimanna PR, Den Otter JJ, Van Schayck CP, Van Herwaarden CL, Folgering H, Van Weel C.
    Br J Gen Pract; 1996 Jan 28; 46(402):15-8. PubMed ID: 8745846
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of hypertension with a new beta blocker-diuretic combination under long-term control].
    Hoffmann H, Hoffmann W.
    Wien Med Wochenschr; 1985 Mar 15; 135(5):127-34. PubMed ID: 2859703
    [Abstract] [Full Text] [Related]

  • 12. Effects of celiprolol, a cardioselective beta-blocker, on respiratory function in asthmatic patients.
    Pujet JC, Dubreuil C, Fleury B, Provendier O, Abella ML.
    Eur Respir J; 1992 Feb 15; 5(2):196-200. PubMed ID: 1348481
    [Abstract] [Full Text] [Related]

  • 13. 24-h ambulatory non-invasive blood pressure monitoring in the assessment of the antihypertensive action of celiprolol.
    Parati G, Pomidossi G, Casadei R, Ravogli A, Trazzi S, Mutti E, Mancia G.
    J Int Med Res; 1988 Feb 15; 16 Suppl 1():52A-61A. PubMed ID: 2975612
    [Abstract] [Full Text] [Related]

  • 14. A comparative study of celiprolol and chlorthalidone in hypertensive patients with reversible airways obstruction.
    Capone P, Mayol R, Mathieu M.
    Br J Clin Pract Suppl; 1985 Jun 15; 40():37-9. PubMed ID: 2864061
    [No Abstract] [Full Text] [Related]

  • 15. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
    Cass LM, Gunawardena KA, Macmahon MM, Bye A.
    Respir Med; 2000 Feb 15; 94(2):166-73. PubMed ID: 10714424
    [Abstract] [Full Text] [Related]

  • 16. The effect of the cardioselective beta blocker celiprolol on pulmonary function in asthmatic patients.
    Schindl R, Würtz J, Hoffmann H.
    J Cardiovasc Pharmacol; 1986 Feb 15; 8 Suppl 4():S99-101. PubMed ID: 2427862
    [Abstract] [Full Text] [Related]

  • 17. [Potential use of indenolol in hypertensive patients with chronic bronchial asthma].
    Della Toffola A, Galietti F, Giorgis GE, Miravalle C, Oliaro A, Palazzo F, Scappaticci E.
    Minerva Med; 1986 Oct 13; 77(39):1819-21. PubMed ID: 3534631
    [Abstract] [Full Text] [Related]

  • 18. [Beta blockade with celiprolol in tardive dyskinesia patients treated with neuroleptics].
    Hebenstreit GF, Hoffmann H, Hoffmann W, Pittner H.
    Wien Klin Wochenschr; 1986 Jun 13; 98(12):388-92. PubMed ID: 2874663
    [Abstract] [Full Text] [Related]

  • 19. [Uricosuric action of a new beta receptor blocker-diuretic drug combination].
    Brandstetter G, Hoffmann H, Maderbacher H, Eslaminejad S.
    Acta Med Austriaca; 1986 Jun 13; 13(2):29-37. PubMed ID: 2876573
    [Abstract] [Full Text] [Related]

  • 20. [The effect of celiprolol on driving ability. An experimental psychological and comparative clinical study].
    Klebel E, Saam R, Hoffmann H.
    Arzneimittelforschung; 1985 Jun 13; 35(12):1850-3. PubMed ID: 2937411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.